Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)

Clinical trial NCT05443854 · UNKNOWN

Trial details

NCT number: NCT05443854
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Sepsis Septic Shock Hematologic Malignancy Tumor Allogeneic Stem Cell Transplantation

Start date: 2022-09-01
Primary completion: 2024-06-01
Enrollment: 340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.